These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 207856)

  • 21. Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
    Itzhak Y; Hiller JM; Gioannini TL; Simon EJ
    Brain Res; 1984 Jan; 291(2):309-15. PubMed ID: 6320961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
    Galetta S; Hahn EF; Nishimura S; Pasternak GW
    Life Sci; 1987 Aug; 41(6):783-7. PubMed ID: 2441221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor.
    Nozaki M; Cho TM
    J Neurochem; 1985 Aug; 45(2):461-4. PubMed ID: 2989428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate receptor binding affected differentially by opiates and opioid peptides.
    Childers SR; Creese I; Snowman AM; Synder SH
    Eur J Pharmacol; 1979 Apr; 55(1):11-8. PubMed ID: 220062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of multiple analgesic opiate receptors.
    Fürst S; Knoll J
    Int J Tissue React; 1985; 7(1):69-77. PubMed ID: 2861170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute configurations and conformations of the opioid agonist and antagonist enantiomers of picenadol.
    Froimowitz M; Cody V
    Chirality; 1995; 7(7):518-25. PubMed ID: 7495643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mu-selective Met-enkephalinamide analogs with antagonist activity. Synthesis, receptor binding, analgesic properties and conformational studies.
    Judd AK; Lawson JA; Olsen CM; Toll LR; Polgar WE; Uyeno ET; Keys CJ; Loew GH
    Int J Pept Protein Res; 1987 Sep; 30(3):299-317. PubMed ID: 2826356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model.
    Perry DC; Mullis KB; Oie S; Sadée W
    Brain Res; 1980 Oct; 199(1):49-61. PubMed ID: 6250676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats.
    Omote K; Kitahata LM; Collins JG; Nakatani K; Nakagawa I
    Anesth Analg; 1990 Jul; 71(1):23-8. PubMed ID: 1973027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.
    Manara L; Bianchi G; Fiocchi R; Notarnicola A; Peracchia F; Tavani A
    Life Sci; 1982 Sep 20-27; 31(12-13):1271-4. PubMed ID: 6183550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel comprehensive opiate-receptor model.
    Kolb VM; Snyder JP
    NIDA Res Monogr; 1986; 75():41-4. PubMed ID: 2828987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists.
    Lattin DL; Caviness B; Hudson RG; Greene DL; Raible PK; Richardson JB
    J Med Chem; 1981 Jul; 24(7):903-6. PubMed ID: 6268789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of arachidonic acid on specific binding of [3H]naloxone to opioid receptors.
    Apaydin S; Oktem HA
    Acta Neurobiol Exp (Wars); 2000; 60(3):361-3. PubMed ID: 11016077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent probes for opioid receptors.
    Kolb VM; Koman A; Terenius L
    Life Sci; 1983; 33 Suppl 1():423-6. PubMed ID: 6319896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights in the clastic binding hypothesis for opiate-receptor interactions I: Electron-transfer mechanism.
    Kolb VM
    J Pharm Sci; 1984 Jun; 73(6):715-9. PubMed ID: 6330344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New developments and findings in the field of opiates, opioids, opiate receptors and complete and partial opiate antagonists].
    Schneider M; Bunge HJ; Heinrich F
    Anaesthesiol Reanim; 1990; 15(3):138-44. PubMed ID: 2168183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity.
    Spivak CE; Beglan CL; Seidleck BK; Hirshbein LD; Blaschak CJ; Uhl GR; Surratt CK
    Mol Pharmacol; 1997 Dec; 52(6):983-92. PubMed ID: 9415708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
    Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT; Horng JS
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):749-52. PubMed ID: 193169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.